XOMA to Announce Fourth Quarter and Year-End 2011 Financial Results and Host Webcast Conference Call on March 14 Mar 07, 2012 4:05pm EST
XOMA Announces Pricing of $39.2 Million Public Offering of Common Stock and Warrants Mar 06, 2012 9:00am EST
XOMA Acquires U.S. Rights to Perindopril Franchise and Establishes Commercial Operations Jan 17, 2012 4:05pm EST